Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIJP Cream for Anal HSIL
NCT00622440Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- May 2008
- Primary completion
- Dec 2012
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
Phase 2, randomised trial in anal squamous intraepithelial lesion (ASIL) comparing AIJP with Placebo (2 arms). Primary endpoint: Final Response of Anal High-grade Squamous Intraepithelial Lesions (HSIL) at 60 weeks. Started May 2008; status: completed.
02
Drugs
Arnebia Indigo Jade Pearl
03
Conditions
anal squamous intraepithelial lesion (ASIL)
Beyond the preview
Go deeper on NCT00622440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00622440.